
Hematologist-Oncologist

No OPD information available
Cutaneous T-Cell Lymphoma (CTCL)
T-Cell Lymphoma
Mycosis Fungoides
Non-Hodgkin Lymphoma
Peripheral T-Cell Lymphoma
Sezary Syndrome
Anaplastic Large Cell Lymphoma
Angioimmunoblastic T-cell Lymphoma
Hodgkin Lymphoma
Lymphofollicular Hyperplasia
Lymphomatoid Papulosis
Carrie A. Van Der Weyden is a female medical professional who specializes in treating different types of lymphomas, which are types of cancer that affect the lymphatic system in the body. Some of the conditions she helps patients with include Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, Non-Hodgkin Lymphoma, and others.
Carrie A. Van Der Weyden uses her special skills and knowledge to provide the best care for her patients. She is known for her expertise in diagnosing and treating various types of lymphomas, which helps her patients feel confident in her abilities.
Patients trust Carrie A. Van Der Weyden because she communicates with them in a caring and understanding way. She takes the time to listen to their concerns and explains their treatment options in a clear and supportive manner.
Carrie A. Van Der Weyden stays updated with the latest medical knowledge and research to ensure that her patients receive the most effective and advanced treatments available. This dedication to learning helps her provide the best care possible for her patients.
In her work, Carrie A. Van Der Weyden collaborates closely with other medical professionals to ensure that her patients receive comprehensive and coordinated care. Her relationships with colleagues are built on mutual respect and a shared commitment to improving patient outcomes.
Carrie A. Van Der Weyden's work has had a positive impact on many patients' lives by providing them with effective treatments and compassionate care. Her dedication to helping patients navigate their health challenges has made a difference in the lives of those she treats.
One of Carrie A. Van Der Weyden's notable publications is "Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: Results from PETAL consortium," which was published in Blood advances on August 29, 2024.
Carrie A. Van Der Weyden's expertise, compassion, and commitment to advancing medical knowledge make her a trusted and respected healthcare professional in the field of lymphoma treatment.
